Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
5.79
-0.20 (-3.34%)
At close: Apr 1, 2025, 4:00 PM
5.97
+0.18 (3.19%)
After-hours: Apr 1, 2025, 6:00 PM EDT

Cogent Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
640862506808342350
Upgrade
Market Cap Growth
70.14%70.14%-37.32%136.30%-2.42%-
Upgrade
Enterprise Value
370644273605228365
Upgrade
Last Close Price
5.797.805.8811.568.5811.23
Upgrade
PS Ratio
----44.52
Upgrade
PB Ratio
4.393.361.963.161.601.49
Upgrade
P/TBV Ratio
5.915.912.564.262.662.83
Upgrade
EV/Sales Ratio
----46.36
Upgrade
Debt / Equity Ratio
0.070.070.070.080.020.02
Upgrade
Asset Turnover
-----0.05
Upgrade
Quick Ratio
5.155.156.969.6612.8618.50
Upgrade
Current Ratio
5.325.327.099.8713.0418.70
Upgrade
Return on Equity (ROE)
-99.54%-99.54%-74.94%-59.69%-32.20%-56.16%
Upgrade
Return on Assets (ROA)
-53.78%-53.78%-42.35%-34.68%-19.55%-14.69%
Upgrade
Return on Capital (ROIC)
-62.67%-62.67%-47.13%-37.51%-20.66%-15.89%
Upgrade
Earnings Yield
-39.98%-29.70%-38.00%-17.36%-21.14%-21.35%
Upgrade
FCF Yield
-32.56%-24.18%-30.89%-15.53%-17.69%-10.23%
Upgrade
Buyback Yield / Dilution
-30.36%-30.36%-35.54%-51.89%-249.52%-45.42%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q